← Open Payments lookup

SUZANNE SWAIN: Open Payments

NPI 1790245678 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$313 in 14 payments from 9 companies in 2025. Trend: 2023 $204 · 2024 $366 · 2025 $313

Food & beverage: $313
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$80
Neurocrine BioSciences, Inc.2$51
Alkermes, Inc.2$48
ABBVIE INC.2$30
Indivior Inc.1$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Vanda Pharmaceuticals Inc.1$20
E.R. Squibb & Sons, L.L.C.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: REXULTI, INGREZZA, ARISTADA, VRAYLAR, SUBLOCADE, CAPLYTA, HETLIOZ, COBENFY.

Industry payments across AZ — which companies pay providers there.